Coxiella burnetii (Q-Fever) Antibodies, IgG and IgM, Phase I and II with Reflex to Titer
Ordering Recommendation
Confirm infectious agent as C. burnetii (Q-fever) in symptomatic patients.
New York DOH Approval Status
Specimen Required
Serum separator tube (SST).
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.4 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" and "convalescent."
Refrigerated.
Contaminated, hemolyzed, or severely lipemic specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Methodology
Qualitative Indirect Fluorescent Antibody (IFA)
Performed
Mon, Wed, Fri
Reported
1-6 days
Reference Interval
Test Number | Components | Reference Interval |
---|---|---|
C. burnetii (Q-Fever) Ab, Phase I IgG | Negative | |
C. burnetii (Q-Fever) Ab, Phase II IgG | Negative | |
C. burnetii (Q-Fever) Ab, Phase I IgM | Negative | |
C. burnetii (Q-Fever) Ab, Phase II IgM | Negative |
Interpretive Data
IgG: Acute Q fever is best demonstrated by a four-fold rise in phase II IgG titers when comparing two serum samples collected 3-6 weeks apart, and testing is performed in the same laboratory at the same time. Phase I IgG titers can increase during seroconversion. However, in the case of acute infection, the phase I IgG titer should remain lower than the phase II titer. In the absence of an acute sample, a single convalescent serum sample with a phase II IgG titer greater than 1:128 in a patient who has been ill greater than 1 week, indicates probable acute Q fever.
Chronic Q fever is best demonstrated by a phase I IgG titer greater than the phase II IgG titer. Phase I and phase II IgG titers may remain elevated for months.
IgM: IgM antibodies to phase II antigens provide ancillary information to IgG titers. Phase II IgM titers develop in the same time period of phase II IgG titers and can persist for over a year. A single phase II IgM positive result on an acute sample represents an early conversion or a false positive; testing of a convalescent serum is necessary. In the absence of an acute sample, a single convalescent serum sample with a phase II IgG titer greater than 1:128 in a patient who has been ill longer than 1 week indicates probable acute Q fever.
Chronic Q fever is best demonstrated by a phase I titer greater than the phase II IgG titer. Phase I IgM antibodies may also develop concurrently with phase I IgG antibodies. However, in the absence of a phase I IgG titer, the diagnostic value of a phase I IgM titer is limited. Phase I and phase II IgM and IgG titers may remain elevated for months or years after acute infection or during convalescence.
FDA
Note
For IgG or IgM testing, if any Phase I or Phase II screening result is Indeterminate or Positive, then titer(s) will be added. Additional charges apply.
Hotline History
Hotline History
CPT Codes
86638 x4; if reflexed add 86638 per titer
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2012626 | C. Burnetii Abs, IgG Phase I Screen | 48720-7 |
2012628 | C. Burnetii Abs, IgG Phase II Screen | 48719-9 |
2012639 | C. burnetii (Q-Fever) Ab, Phase I IgM | 63455-0 |
2012641 | C. burnetii (Q-Fever) Ab, Phase II IgM | 43928-1 |
Aliases
- Coxiella burnetii
- Coxiella Titer
- Q Fever Phase I IFA
- Q Fever Phase II IFA